Brendon Moodley, DPM
Foot & Ankle Surgery · Redmond, WANPI 1275566549
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Stryker at 49.7% of the total. Reporting peaked in 2019 at $1,580 and has fallen 74.7% since, to $400 in 2025.
Across 63 payments — averaging $89.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$1K
- Bioventus LLC$225
- Linvatec Corporation$194
- Trice Medical, Inc.$65
- plus $158 from 4 others
What the payments were for
- Travel & lodging$3,09755%
- Food & beverage$2,52645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 34 | $2,793 |
| Paragon 28, Inc. | 5 | $1,115 |
| Treace Medical Concepts, Inc. | 10 | $1,073 |
| Bioventus LLC | 4 | $225 |
| Linvatec Corporation | 2 | $194 |
| Trice Medical, Inc. | 1 | $65 |
| Zimmer Biomet | 3 | $60 |
| Orthofix Medical, Inc. | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| Johnson & Johnson | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$967
- Lapiplasty System$766
- PROCINCH$581
- NANOTACK FLEX$176
- ICONIX$172
- BioBrace 23mm$145
How this compares
$5,623 in reported general payments places this provider in the 70th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 27 | $258 |
| Terbinafine Hcl | 13 | $98 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $83 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Redmond
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
- Garrett PereskoMorton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.